Cooley advised Zepto on the fundraising. Zepto announced its $200 million Series E financing, which brings its valuation to $1.4 billion. StepStone Group led the financing round,...
You must be a Standard 1 Year member to access this content.
Cooley advised Cellares on the fundraising. Cellares has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies. In connection with the...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Genesis Therapeutics in the fundraising, and Cooley represented Andreessen Horowitz (a16z) Bio + Health Tech Investments. Genesis Therapeutics announced that it has...
You must be a Standard 1 Year member to access this content.
Cooley advised Ramp on the fundraising. Ramp announced a $300 million Series D on the back of strong revenue growth, rapidly increasing market share among small...
You must be a Standard 1 Year member to access this content.
Cooley advised Definitive Healthcare on the deal. Definitive Healthcare (Nasdaq: DH) announced its acquisition of Populi for $52 million in an all-cash transaction. This acquisition furthers Definitive...
You must be a Standard 1 Year member to access this content.
Cooley, alongside a team from Quinn Emanuel Urquhart & Sullivan, secured a summary judgment victory for the National Association of Realtors (NAR) in a high-stakes antitrust...
You must be a Standard 1 Year member to access this content.
Morrison Foerster advised Celadon Partners and GeneFab, while Cooley and Goodwin Procter advised Senti Biosciences. Senti Biosciences, Inc. (Nasdaq: SNTI) and Celadon Partners, LLC announced a transaction...
You must be a Standard 1 Year member to access this content.
Ropes & Gray acted as legal advisor to TransMedics, and Cooley acted as legal advisor to Bridge to Life. TransMedics Group, Inc. (Nasdaq: TMDX) announced that is...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Poseida Therapeutics on the deal. Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Poseida Therapeutics, Inc. (NASDAQ: PSTX, CEO:...
You must be a Standard 1 Year member to access this content.
Cooley acted as U.S. legal advisor to Vietnam Sunergy Cell Company, and Robinson & Cole acted as U.S. legal advisor to Blue World. Vietnam Sunergy Cell...
You must be a Standard 1 Year member to access this content.
Cooley advised Gracell Biotechnologies; and Davis Polk & Wardwell advised the placement agents on the deal. Gracell Biotechnologies Inc. (Nasdaq: GRCL) announced that it has entered into a...
You must be a Standard 1 Year member to access this content.
Cooley advised Lemonaide on the deal. BeatStars announced its strategic alliance with Lemonaide. The partnership between Lemonaide and BeatStars is compelling because of both companies’ shared commitment...
You must be a Standard 1 Year member to access this content.
